The enteral feeding has become an integral part of modern clinical nutrition, as it provides a life-sustaining nutritional support for patients who are unable to fulfil their dietary needs through normal oral intake. The rising incidences of cancer, neurological disorders, gastrointestinal diseases, diabetes and age-related disorders have led to a significant rise in the demand for medically formulated enteral nutrition in hospitals, rehabilitation centres, long-term care facilities, and home healthcare settings.
Today’s enteral feeding formulas have grown from basic nutritional supplements into highly specialised products that address specific medical conditions and patient populations. Disease-specific formulations, peptide-based nutrition, immune-supporting ingredients and whole-food-based formulas are improving patient outcomes while supporting personalised nutritional care. Simultaneously, improvements in portable feeding devices, home enteral nutrition (HEN), and telehealth monitoring are increasing the feasibility of long-term nutritional therapy outside of traditional hospital environments.
According to SNS Insider, the U.S. Enteral Feeding Formulas Market was valued at approximately USD 2.19 billion in 2024 and is projected to reach USD 3.87 billion by 2032, driven by the growing adoption of home enteral nutrition, increasing prevalence of chronic diseases, and expanding reimbursement support for medical nutrition therapies. Globally, the Enteral Feeding Formulas Market was valued at USD 7.21 billion in 2024 and is expected to reach USD 12.82 billion by 2032, expanding at a CAGR of 7.48% during 2025–2032 as healthcare providers increasingly prioritize specialized nutritional interventions for acute and chronic disease management.
Gain Actionable Intelligence on the Enteral Feeding Formulas Market - Request a Sample Report
U.S. Enteral Feeding Formulas Market Analysis
The U.S. is one of the largest markets for enteral feeding formulas due to advanced healthcare infrastructure, strong clinical nutrition guidelines, and increasing prevalence of chronic diseases requiring long-term nutritional support. Hospitals, intensive care units, oncology centres, rehabilitation facilities and home healthcare providers continue to extend the use of enteral nutrition to improve recovery and reduce complications among the patients who cannot consume adequate nutrition orally.
One of the key trends affecting the U.S. market is the rapid growth of home enteral nutrition (HEN). Due to the COVID-19 pandemic, healthcare providers have been moving nutritional care from the hospital to the home to allow patients to receive long-term enteral nutrition more comfortably and minimise healthcare costs. Medicare, Medicaid and private insurance reimbursement programmes have provided even more incentive for adoption, by supporting medically necessary enteral feeding therapies.
U.S. healthcare is being driven by increasing awareness of disease-specific nutrition, personalised feeding protocols and specialised formulations for oncology, diabetes, gastrointestinal disorders and neurological diseases.
Top 5 Leading Enteral Feeding Formula Companies
1. Abbott
Abbott is still one of the world's leading clinical nutrition companies with its wide range of enteral feeding products for adult and paediatric patients. The Firm’s specialised nutrition solutions are designed for patients with gastrointestinal disorders, diabetes, oncology-related malnutrition and critical care needs.
Abbott continues to invest in disease-specific formulations and advanced nutritional science, as well as in expanding products that improve gastrointestinal tolerance and patient outcomes in hospital and home healthcare settings.
2. Nestlé Health Science
Nestlé Health Science is a world leader in medical nutrition and offers specialised enteral feeding formulas for a variety of clinical conditions. Its portfolio addresses nutritional requirements in oncology, neurology, gastrointestinal disorders and critical care.
The company is further enhancing its leading position by conducting ongoing research into personalised nutrition, generating clinical evidence and developing innovative nutritional therapies that support better patient recovery and long-term health management.
3. Danone Nutricia
Danone Nutricia provides a wide range of products in medical nutrition, including specialist enteral nutrition for patients with complex healthcare needs. It offers clinically established recipes for disease-specific nutrition therapy in hospitals, rehabilitation centres and home care.
It has been able to consolidate its leading position in the global clinical nutrition market with its focus on scientific research and patient-oriented nutritional solutions.
4. Fresenius Kabi
Fresenius Kabi provides a broad portfolio of clinical nutrition products in addition to infusion therapies and medical technologies. Its enteral nutrition portfolio supports patients requiring specialised nutritional care in intensive care units, surgical recovery, oncology treatment and long-term disease management.
The company’s integrated healthcare solutions and strong hospital presence continue to expand access to advanced nutritional support globally.
5. Kate Farms
Kate Farms is pioneering plant-based medical nutrition by providing organic enteral feeding formulas for patients who need high-quality nutritional support. Its products are finding greater acceptance among healthcare providers who want plant-based formulas but still want complete nutritional profiles.
The company’s focus on clean-label formulations and home enteral nutrition continues to support the rising demand for personalised nutritional care.
What the Future of Enteral Feeding Formulas Holds
The future of enteral feeding will be shaped by Personalisation, better clinical outcomes and the growing expansion of home healthcare. Advances in nutritional science are allowing the development of formulas customised to diseases such as diabetes, cancer, kidney disease, gastrointestinal disorders, and neurological disorders, allowing clinicians to provide more specific and effective nutritional support.
The adoption of home enteral nutrition, portable feeding pumps, remote patient monitoring and telemedicine services is increasing, leading to reduced dependence on extended hospital stays, while enhancing patient comfort and reducing healthcare costs. health providers are increasingly realising that diet is a basic part of disease management, not just supportive care. This development and advances in delivery of care are increasing the significance of enteral nutrition in acute and long-term care.
Increasing global burden of chronic diseases and the ongoing need for nutritional support for ageing population are expected to drive the robust market for professionally approved enteral feeding formulae. The market is expected to grow steadily during the forecast period. The US is expected to dominate the market owing to the presence of well-established healthcare infrastructure, robust reimbursement policies, and rising home healthcare programmes.
